Cargando…

PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.

Detalles Bibliográficos
Autores principales: Christopher, D., Abdul Halim, N. A., Gallardo, C. A., Lim, G. H., Jen, W. Y., Lin, C. Y., Bingwen, E. F., Ooi, M., Chee, Y. L., Sampath, V. S., Wong, G. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428985/
http://dx.doi.org/10.1097/01.HS9.0000850104.80221.19
_version_ 1784779291212382208
author Christopher, D.
Abdul Halim, N. A.
Gallardo, C. A.
Lim, G. H.
Jen, W. Y.
Lin, C. Y.
Bingwen, E. F.
Ooi, M.
Chee, Y. L.
Sampath, V. S.
Wong, G. C.
author_facet Christopher, D.
Abdul Halim, N. A.
Gallardo, C. A.
Lim, G. H.
Jen, W. Y.
Lin, C. Y.
Bingwen, E. F.
Ooi, M.
Chee, Y. L.
Sampath, V. S.
Wong, G. C.
author_sort Christopher, D.
collection PubMed
description
format Online
Article
Text
id pubmed-9428985
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94289852022-08-31 PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE. Christopher, D. Abdul Halim, N. A. Gallardo, C. A. Lim, G. H. Jen, W. Y. Lin, C. Y. Bingwen, E. F. Ooi, M. Chee, Y. L. Sampath, V. S. Wong, G. C. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428985/ http://dx.doi.org/10.1097/01.HS9.0000850104.80221.19 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Christopher, D.
Abdul Halim, N. A.
Gallardo, C. A.
Lim, G. H.
Jen, W. Y.
Lin, C. Y.
Bingwen, E. F.
Ooi, M.
Chee, Y. L.
Sampath, V. S.
Wong, G. C.
PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.
title PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.
title_full PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.
title_fullStr PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.
title_full_unstemmed PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.
title_short PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.
title_sort pb1813: efficacy of azacitidine and venetoclax in aml patients may be limited by interaction with posaconazole and lack of standardised treatment protocol. real world data from 3 major centres in singapore.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428985/
http://dx.doi.org/10.1097/01.HS9.0000850104.80221.19
work_keys_str_mv AT christopherd pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT abdulhalimna pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT gallardoca pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT limgh pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT jenwy pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT lincy pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT bingwenef pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT ooim pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT cheeyl pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT sampathvs pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore
AT wonggc pb1813efficacyofazacitidineandvenetoclaxinamlpatientsmaybelimitedbyinteractionwithposaconazoleandlackofstandardisedtreatmentprotocolrealworlddatafrom3majorcentresinsingapore